We have discussed a lot of weight loss drugs based on GLP-1 receptor agonists, and setmelanotide, a new weight loss therapy based on the melanocortin receptor (MC4R) , is approved for the treatment of inherited obesity caused by genetic defects, which is a new breakthrough in the treatment of obesity. Cas:920014-72-8 MF:C49H68N10O9S2 MW: 1117.32 Know Setmelanotide It is a novel …